Galmed Pharmaceuticals Ltd. GLMD
$ 3.08
-1.29%
Annual report 2023
added 12-21-2024
Galmed Pharmaceuticals Ltd. Income Statement 2011-2024 | GLMD
Annual Income Statement Galmed Pharmaceuticals Ltd.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
1.16 M | 20.2 M | 36.1 M | 84.7 M | 102 M | 149 M | 63.9 M | 46.1 M | 69.4 M | 67.3 M | - | - | - |
Shares |
2.77 M | 25.2 M | 25.1 M | 21.3 M | 21.1 M | 18.1 M | 12.5 M | 11.4 M | 11.1 M | 10.3 M | - | - | - |
Historical Prices |
0.42 | 0.8 | 1.44 | 3.97 | 4.85 | 8.24 | 5.12 | 5.2 | 4.61 | 9.49 | - | - | - |
Net Income |
-6.91 M | -17.9 M | -32.5 M | -28.8 M | -20.5 M | -9.86 M | -12.3 M | -17 M | 10.6 M | 9.1 M | -17.5 M | -3.15 M | - |
Revenue |
- | - | - | - | - | 2.04 M | 1.08 M | 467 K | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | -30.2 M | -22.4 M | -10.7 M | -12.4 M | - | - | - | - | - | - |
Interest Expense |
- | - | -414 K | -1.44 M | -1.92 M | 934 K | 65 K | 35 K | - | - | - | - | - |
EBITDA |
- | - | 42 K | -30.2 M | -22.3 M | -10.3 M | -12.1 M | -16.7 M | 10.7 M | 9.11 M | -14.6 M | -3.13 M | - |
Operating Expenses |
- | - | 32.9 M | - | 22.4 M | 12.8 M | 13.4 M | 17.3 M | 10.9 M | 9.14 M | - | - | - |
General and Administrative Expenses |
- | - | 5.66 M | 4.13 M | 4.2 M | 4.44 M | 3.8 M | 3.08 M | 3.25 M | 2.48 M | 7.36 M | 694 K | - |
All numbers in USD currency
Quarterly Income Statement Galmed Pharmaceuticals Ltd.
2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
- | - | - | - | 25.1 M | - | 25.1 M | - | 21.3 M | - | 21.2 M | - | 21.1 M | - | 21.1 M | - | 21 M | - | 15.7 M | - | 14.4 M | - | 12.2 M | - | 12.1 M | - | 11.1 M | - | 11.1 M | - | 11.1 M | - | 11.1 M | - | - | - | 9.74 K | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
- | - | - | - | - | - | -8.4 M | -8.9 M | - | - | -5.53 M | -6.06 M | - | - | -4.17 M | -3.49 M | - | - | -2.68 M | -2.51 M | - | - | -2.69 M | - | - | - | -4.31 M | - | - | - | -2.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 270 K | - | - | - | 270 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
- | - | - | - | - | - | - | - | - | - | -5.82 M | - | - | - | -4.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | 290 K | - | - | - | 532 K | - | - | - | 90 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | - | - | - | - | -5.82 M | - | - | - | -4.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
- | - | - | - | - | - | 8.41 M | - | - | - | 5.82 M | - | - | - | 4.7 M | - | - | - | 2.78 M | - | - | - | 2.7 M | - | - | - | 4.22 M | - | - | - | 2.53 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
- | - | - | - | - | - | 1.38 M | - | - | - | 845 K | - | - | - | 1.21 M | - | - | - | 1.1 M | - | - | - | 624 K | - | - | - | 861 K | - | - | - | 967 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency